Pregnancy and liver disease

Rachel H. Westbrook; Geoffrey Dusheiko; Catherine Williamson

doi:10.1016/j.jhep.2015.11.030

Pregnancy and liver disease

Rachel H. Westbrook, Geoffrey Dusheiko, Catherine Williamson

Research output: Contribution to journal › Article › peer-review

190 Citations (Scopus)

Abstract

ACR, acute cellular rejection; AFLP, acute fatty liver of pregnancy; BCS, Budd-Chiari syndrome; HELLP, haemolysis, elevated liver enzymes and low platelets syndrome; HEV, hepatitis E virus; HBsAg, hepatitis B surface antigen; HCV, hepatitis C virus; HG, hyperemesis gravidarum; ICP, intrahepatic cholestasis of pregnancy; MELD, model for end stage liver disease; UDCA, ursodeoxycholic acid

Original language	English
Pages (from-to)	933-945
Number of pages	13
Journal	Journal of Hepatology
Volume	64
Issue number	4
DOIs	https://doi.org/10.1016/j.jhep.2015.11.030
Publication status	Published - Apr 2016

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.jhep.2015.11.030

Cite this

@article{ac248e6646674bd7b733b94d368dab96,

title = "Pregnancy and liver disease",

abstract = "ACR, acute cellular rejection; AFLP, acute fatty liver of pregnancy; BCS, Budd-Chiari syndrome; HELLP, haemolysis, elevated liver enzymes and low platelets syndrome; HEV, hepatitis E virus; HBsAg, hepatitis B surface antigen; HCV, hepatitis C virus; HG, hyperemesis gravidarum; ICP, intrahepatic cholestasis of pregnancy; MELD, model for end stage liver disease; UDCA, ursodeoxycholic acid",

author = "Westbrook, {Rachel H.} and Geoffrey Dusheiko and Catherine Williamson",

year = "2016",

month = apr,

doi = "10.1016/j.jhep.2015.11.030",

language = "English",

volume = "64",

pages = "933--945",

journal = "Journal of Hepatology",

issn = "0168-8278",

publisher = "Elsevier",

number = "4",

}

TY - JOUR

T1 - Pregnancy and liver disease

AU - Westbrook, Rachel H.

AU - Dusheiko, Geoffrey

AU - Williamson, Catherine

PY - 2016/4

Y1 - 2016/4

N2 - ACR, acute cellular rejection; AFLP, acute fatty liver of pregnancy; BCS, Budd-Chiari syndrome; HELLP, haemolysis, elevated liver enzymes and low platelets syndrome; HEV, hepatitis E virus; HBsAg, hepatitis B surface antigen; HCV, hepatitis C virus; HG, hyperemesis gravidarum; ICP, intrahepatic cholestasis of pregnancy; MELD, model for end stage liver disease; UDCA, ursodeoxycholic acid

AB - ACR, acute cellular rejection; AFLP, acute fatty liver of pregnancy; BCS, Budd-Chiari syndrome; HELLP, haemolysis, elevated liver enzymes and low platelets syndrome; HEV, hepatitis E virus; HBsAg, hepatitis B surface antigen; HCV, hepatitis C virus; HG, hyperemesis gravidarum; ICP, intrahepatic cholestasis of pregnancy; MELD, model for end stage liver disease; UDCA, ursodeoxycholic acid

U2 - 10.1016/j.jhep.2015.11.030

DO - 10.1016/j.jhep.2015.11.030

M3 - Article

C2 - 26658682

SN - 0168-8278

VL - 64

SP - 933

EP - 945

JO - Journal of Hepatology

JF - Journal of Hepatology

IS - 4

ER -

Pregnancy and liver disease

Abstract

UN SDGs

Access to Document

Fingerprint

Cite this